[opensourcepharma] go Mat! and go alternative models!

Jaykumar Menon jaykumar.menon at mcgill.ca
Thu Dec 1 16:20:53 UTC 2016


Dear all,

Fantastic stratagem from Mat and the U of Sydney and Open Source Malaria, cleverly highlighting the high cost of drugs and making global news!  In the New York press, poor Shkreli is called the "pharma bro".   Not that his business model is altogether different from that of many other firms.

http://www.smh.com.au/technology/sci-tech/sydney-schoolboys-take-down-martin-shkreli-the-most-hated-man-in-the-world-20161125-gsxcu5

Martin Shkreli was the ''big pharma bro" who outraged the world by hiking the price of an essential drug from $US13.50 ($18) to $US750 a tablet.

Now a handful of year 11 students in Sydney have shown him up, cooking the same drug in their school lab for about $2 a dose.

http://nypost.com/2016/12/01/kids-school-pharma-bro-recreating-750-drug-for-2/
Notorious pharma exec Martin Shkreli is downplaying the success of high school students who recreated his $750 life-saving medication for just $2, saying "anyone can make any drug" and denying he got "owned" by the junior scientists.

j


Jaykumar Menon, J.D., M.I.A.
Professor of Practice
McGill University Institute for the Study of International Development
[McGill ISID logo small]
Peterson Hall, Room 128
3460 McTavish Street
Montreal, Quebec H3A 0E6

Research Fellow
Centre for International Sustainable Development Law

Tel: 514-398-3507
Fax:  514-398-8432
North America mobile:  +1-917-302-0722
Email:  jaykumar.menon at mcgill.ca <mailto:jaykumar.menon at mcgill.ca>
Skype:  jmenon1
Viber/WhatsApp:  917 302 0722
India mobile:  +91 95 99 00 5886

-------------- next part --------------
An HTML attachment was scrubbed...
URL: <http://lists.okfn.org/pipermail/opensourcepharma/attachments/20161201/68ebafa6/attachment.html>
-------------- next part --------------
A non-text attachment was scrubbed...
Name: image001.jpg
Type: image/jpeg
Size: 2995 bytes
Desc: image001.jpg
URL: <http://lists.okfn.org/pipermail/opensourcepharma/attachments/20161201/68ebafa6/attachment.jpg>


More information about the opensourcepharma mailing list